Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nutriband Inc
(NQ:
NTRB
)
3.650
-0.200 (-5.19%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nutriband Inc
< Previous
1
2
3
4
Next >
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise
Today 13:44 EDT
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Closes $8.4M Private Placement
April 24, 2024
Via
Investor Brand Network
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
April 24, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Enters Exclusive Supplier Agreement with Major Sports Brand Licensee
April 23, 2024
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Nutriband Inc. Announces $8.4M Private Placement
April 19, 2024
Via
ACCESSWIRE
Nutriband Inc. (NASDAQ: NTRB) Highlighted for Surprising Price Action
March 22, 2024
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Advances Abuse Deterrent Tech Addressing Fentanyl Epidemic
April 23, 2024
Via
Investor Brand Network
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
April 23, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Enters Into Private Placement Agreements to Raise Funds for Development of AVERSA Fentanyl
April 19, 2024
Via
Investor Brand Network
Exposures
Product Safety
Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
April 10, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st
January 29, 2024
Via
ACCESSWIRE
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 20, 2023
Via
ACCESSWIRE
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
September 12, 2023
Via
ACCESSWIRE
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador
August 30, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Begins Manufacturing for Major Sports Brand Licensee
April 01, 2024
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
April 01, 2024
Via
ACCESSWIRE
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
March 27, 2024
Via
ACCESSWIRE
Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting
March 25, 2024
Via
ACCESSWIRE
Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
March 04, 2024
Via
ACCESSWIRE
Nutriband CEO Publishes Letter to Shareholders
January 26, 2024
Via
ACCESSWIRE
Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 05, 2024
Via
ACCESSWIRE
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
November 28, 2023
Via
ACCESSWIRE
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
November 08, 2023
Via
ACCESSWIRE
Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales 0f $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm
October 11, 2023
Via
ACCESSWIRE
Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications
September 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
September 20, 2023
ORLANDO, FL / September 20, 2023 (PlatoData via 500NewsWire) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance...
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 20, 2023
Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
September 11, 2023
Via
ACCESSWIRE
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
September 20, 2023
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
July 27, 2023
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.